Skip to main content

Bulls on the Comeback Trail

Traders overlook Pfizer woes and focus on M&A activity and the desire to push ahead into the new year.


Aaron L. Task is the co-executive editor of In keeping with TSC's editorial policy, he doesn't own or short individual stocks, although he owns stock in He also doesn't invest in hedge funds or other private investment partnerships. He appreciates your feedback;

click here

to send him an email.

Scroll to Continue

TheStreet Recommends